|
End-of-day quote
Berne S.E.
2026-09-04
|
5-day change | 1st Jan Change | ||
| 135.15 CHF | +2.81% |
|
+2.97% | -6.70% |
| 06:26pm | AstraZeneca Wins FDA Accelerated Approval for Breast Cancer Drug Etcamah | MT |
| 09-04 | AstraZeneca Gets FDA Approval for Breast Cancer Treatment | DJ |
| Market Cap | 252B 217B 204B 186B 348B 23,789B 350B 2,408B 935B 12,194B 945B 925B 39,334B | P/E 2026 * |
20.9x | P/E 2027 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise Value | 271B 234B 219B 201B 375B 25,628B 377B 2,595B 1,007B 13,137B 1,018B 996B 42,375B | EV / Sales 2026 * |
4.29x | EV / Sales 2027 * | 3.94x |
| Free-Float |
96.63% | Yield 2026 * |
2.06% | Yield 2027 * | 2.19% |
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| AZN | Delayed | |
NYSE
| AZN | End-of-day quote | |
|
Nasdaq Stockholm
| AZN | Delayed | |
|
CBOE
| AZN | Real-time | |
|
CBOE
| AZNs | Real-time | |
|
CBOE
| AZN | Real-time | |
|
Tradegate
| ZEG | Real-time | |
|
Mexican S.E.
| AZN1 N | End-of-day quote | |
|
Boerse Muenchen
| ZEG | Real-time | |
|
CBOE
| AZN | Real-time | |
|
Deutsche Boerse AG
| ZEG | Delayed | |
|
Börse Stuttgart
| ZEG | Delayed | |
|
Berne S.E.
| 000982352 | End-of-day quote |
Last Transcript : AstraZeneca PLC
| 1 day | +2.81% | ||
| 1 week | +2.97% | ||
| Current month | +1.84% | ||
| 1 month | +7.83% | ||
| 3 months | -1.36% | ||
| 6 months | -11.24% | ||
| Current year | -6.70% |
| 1 week | 131.45 |  | 135.15 |
| 1 month | 124.91 | | 135.15 |
| Current year | 124.91 | | 163 |
| 1 year | 116.75 | | 163 |
| 3 years | 104.86 | | 163 |
| 5 years | 95 | | 163 |
| 10 years | 52.7 | | 163 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 2012-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 2021-07-31 |
Jeffrey Pott
CMP | Compliance Officer | - | 2022-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 1999-04-05 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 2012-09-30 |
Philip Broadley
BRD | Director/Board Member | 65 | 2017-04-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.81% | +2.97% | - | - | 255B | |
| -0.88% | -2.27% | +55.78% | +106.31% | 1,034B | |
| -1.15% | +3.56% | +54.62% | +71.50% | 671B | |
| -1.44% | -0.65% | +21.05% | +73.05% | 460B | |
| +0.14% | -1.92% | +32.47% | +37.60% | 353B | |
| -1.33% | +3.96% | +25.71% | +45.03% | 309B | |
| -1.15% | -0.89% | -1.67% | +12.21% | 255B | |
| -1.55% | +0.05% | +54.04% | +70.32% | 240B | |
| -0.88% | +1.24% | -18.03% | -54.06% | 207B | |
| -0.15% | +1.43% | +33.64% | +96.99% | 188B | |
| Average | -0.38% | +1.27% | +28.62% | +50.99% | 412.97B | |
| Weighted average by Cap. | -0.37% | +1.04% | +37.27% | +66.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.25B 54.47B 51.17B 46.78B 87.52B 5,976B 87.82B 605B 235B 3,063B 237B 232B 9,881B | 66.85B 57.57B 54.08B 49.44B 92.5B 6,316B 92.83B 639B 248B 3,238B 251B 246B 10,444B |
| Net income | 12.02B 10.35B 9.72B 8.89B 16.63B 1,135B 16.69B 115B 44.64B 582B 45.12B 44.14B 1,877B | 13.7B 11.8B 11.08B 10.13B 18.96B 1,294B 19.02B 131B 50.89B 664B 51.44B 50.32B 2,140B |
| Net Debt | 19.46B 16.76B 15.74B 14.39B 26.93B 1,839B 27.02B 186B 72.29B 943B 73.07B 71.48B 3,040B | 11.79B 10.15B 9.54B 8.72B 16.31B 1,114B 16.37B 113B 43.78B 571B 44.26B 43.3B 1,842B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | CHF 135.15 | +2.81% | 45 |
| 26-09-02 | CHF 131.45 | -0.95% | 24 |
| 26-08-31 | CHF 132.71 | +0.36% | 41 |
| 26-08-28 | CHF 132.24 | +0.75% | 1 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- 000982352 Stock
Select your edition
All financial news and data tailored to specific country editions
